Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Cisplatin and Radiotherapy in High-Risk Head and Neck Cancer
NCT00002670Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Sep 1995
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by NRG Oncology. Primary endpoint: Locoregional Control Rates. Started Sep 1995; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00002670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002670.